
Maury A. Audet
Examiner (ID: 8350, Phone: (571)272-0960 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1658, 1675 |
| Total Applications | 1578 |
| Issued Applications | 696 |
| Pending Applications | 267 |
| Abandoned Applications | 656 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18142161
[patent_doc_number] => 20230016005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => BRAIN FUNCTION REGULATING AGENT, AND FOOD OR BEVERAGE PRODUCT CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/946098
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946098 | BRAIN FUNCTION REGULATING AGENT, AND FOOD OR BEVERAGE PRODUCT CONTAINING SAME | Sep 15, 2022 | Pending |
Array
(
[id] => 18537498
[patent_doc_number] => 20230242592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/822099
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822099 | IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF | Aug 23, 2022 | Pending |
Array
(
[id] => 18244664
[patent_doc_number] => 20230076975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => PEPTIDE AND PROTEIN C-TERMINUS LABELING
[patent_app_type] => utility
[patent_app_number] => 17/820646
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820646 | PEPTIDE AND PROTEIN C-TERMINUS LABELING | Aug 17, 2022 | Pending |
Array
(
[id] => 18195961
[patent_doc_number] => 20230049480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/864645
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864645
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864645 | STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | Jul 13, 2022 | Abandoned |
Array
(
[id] => 20466609
[patent_doc_number] => 12522642
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Recombinant protein comprising multiple multi-peptide sets, pharmaceutical composition comprising the recombinant protein, and method for preparing the recombinant protein
[patent_app_type] => utility
[patent_app_number] => 17/854918
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 960
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854918 | Recombinant protein comprising multiple multi-peptide sets, pharmaceutical composition comprising the recombinant protein, and method for preparing the recombinant protein | Jun 29, 2022 | Issued |
Array
(
[id] => 17836450
[patent_doc_number] => 20220273755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PHARMACEUTICAL COMPOSITION, USE AND METHOD FOR APPLYING GANODERMA MICROSPORUM IMMUNOMODULATORY PROTEIN AND KEYHOLE LIMPET HEMOCYANIN IN CARCINOMA TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/664040
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/664040 | PHARMACEUTICAL COMPOSITION, USE AND METHOD FOR APPLYING GANODERMA MICROSPORUM IMMUNOMODULATORY PROTEIN AND KEYHOLE LIMPET HEMOCYANIN IN CARCINOMA TREATMENT | May 17, 2022 | Pending |
Array
(
[id] => 17808755
[patent_doc_number] => 20220260590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/662783
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662783 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | May 9, 2022 | Pending |
Array
(
[id] => 18159756
[patent_doc_number] => 20230026348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => NITROXYLATED PROTEINS AND METHODS FOR THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/740001
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740001 | NITROXYLATED PROTEINS AND METHODS FOR THE USE THEREOF | May 8, 2022 | Abandoned |
Array
(
[id] => 17790511
[patent_doc_number] => 20220249602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => C-TERMINAL FRAGMENT OF TETANUS TOXIN (HC) FOR TREATMENT OF DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/729502
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729502 | C-terminal fragment of tetanus toxin (HC) for treatment of depression | Apr 25, 2022 | Issued |
Array
(
[id] => 17790509
[patent_doc_number] => 20220249600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/657885
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17657885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/657885 | Antimicrobial compositions and methods of use thereof | Apr 3, 2022 | Issued |
Array
(
[id] => 17881203
[patent_doc_number] => 20220296680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => TREATMENT AND PREVENTION OF CARDIORENAL DAMAGE
[patent_app_type] => utility
[patent_app_number] => 17/700836
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700836 | TREATMENT AND PREVENTION OF CARDIORENAL DAMAGE | Mar 21, 2022 | Abandoned |
Array
(
[id] => 18212045
[patent_doc_number] => 20230058309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 17/695071
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695071 | SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE | Mar 14, 2022 | Abandoned |
Array
(
[id] => 17805868
[patent_doc_number] => 20220257703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/691610
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691610 | Proteins for the treatment of epithelial barrier function disorders | Mar 9, 2022 | Issued |
Array
(
[id] => 17671046
[patent_doc_number] => 20220184213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => NOVEL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/687864
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687864 | NOVEL FORMULATIONS | Mar 6, 2022 | Abandoned |
Array
(
[id] => 18169137
[patent_doc_number] => 20230035748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => METHODS AND COMPOSITIONS COMPRISING A CT20 PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/687635
[patent_app_country] => US
[patent_app_date] => 2022-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687635 | METHODS AND COMPOSITIONS COMPRISING A CT20 PEPTIDE | Mar 4, 2022 | Pending |
Array
(
[id] => 17865433
[patent_doc_number] => 20220288168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => LONG ACTING AMYLIN RECEPTOR AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/684578
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684578 | Long acting amylin receptor agonists and uses thereof | Mar 1, 2022 | Issued |
Array
(
[id] => 19112795
[patent_doc_number] => 20240124545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/042937
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042937
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042937 | COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF DISEASES | Feb 15, 2022 | Pending |
Array
(
[id] => 18075908
[patent_doc_number] => 20220401520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => METHODS OF TREATING MILD BRAIN INJURY
[patent_app_type] => utility
[patent_app_number] => 17/665360
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665360 | METHODS OF TREATING MILD BRAIN INJURY | Feb 3, 2022 | Pending |
Array
(
[id] => 17749607
[patent_doc_number] => 20220227811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/590875
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590875 | HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES | Feb 1, 2022 | Pending |
Array
(
[id] => 17760033
[patent_doc_number] => 20220233645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/587311
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587311
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587311 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE | Jan 27, 2022 | Abandoned |